Lataa...
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
BACKGROUND: Vedolizumab has become a standard treatment for the inflammatory bowel diseases ulcerative colitis (UC) and Crohn’s disease (CD). However, there is an ongoing debate on the ideal individual treatment algorithms and means to predict treatment response are not routinely established. AIMS:...
Tallennettuna:
| Julkaisussa: | BMC Gastroenterol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7821503/ https://ncbi.nlm.nih.gov/pubmed/33482730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-021-01604-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|